Metformin Wockhardt Uk

Metformin, the active ingredient in Metformin Wockhardt UK, is a biguanide presented as an unknown/unknown for oral use. It treats type 2 diabetes mellitus in adults by improving blood‑glucose control.

GNH USA supplies Metformin Wockhardt UK as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin is an oral antidiabetic agent used primarily in the management of glucose metabolism disorders.

Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. Prediabetes (impaired fasting glucose): helps delay progression to overt diabetes. Gestational diabetes (when indicated): assists in achieving glycaemic targets during pregnancy.

Metformin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea or upset stomach - Diarrhoea - Abdominal discomfort or cramping - Metallic taste in the mouth - Weight loss - Vitamin B12 level reduction (mild)

Serious or Rare Side Effects: - Lactic acidosis (potentially fatal) - Severe skin reactions such as Stevens‑Johnson syndrome - Hepatic dysfunction - Hypoglycaemia (rare when combined with other glucose‑lowering agents) - Anaphylactic reactions - Persistent elevated serum creatinine indicating renal impairment

Metformin requires careful monitoring in several clinical situations.

Renal function assessment: ensure adequate glomerular filtration before initiation and periodically thereafter. Hepatic disease evaluation: avoid use in patients with significant liver impairment. Risk of lactic acidosis: discontinue before surgeries or procedures involving iodinated contrast. Elderly dosing: consider lower starting doses and monitor for accumulation. Concomitant medication review: assess for drugs that may affect renal clearance or increase acidosis risk. Store at room temperature: keep in the original container, protect from moisture and heat.

Metformin may interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Alcohol: increases risk of lactic acidosis. - Iodinated contrast agents: can precipitate acute renal failure, raising metformin levels. - Cimetidine: may raise plasma concentrations of metformin.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor renal function and potassium. - Loop or thiazide diuretics: assess for dehydration and renal impairment. - Beta‑blockers: may mask hypoglycaemia symptoms. - NSAIDs: can reduce renal perfusion, increasing metformin exposure. - Oral contraceptives: may modestly raise metformin levels.